World-Renowned UF Health Biochemistry Researcher Mavis Agbandje-McKenna, Ph.D., Dies
University of Florida Health biochemistry professor Mavis Agbandje-McKenna, Ph.D., whose world-renowned work on the detailed structure of viruses led to advances in gene therapy treatments for different diseases, died Wednesday (March 3) at her home near Gainesville of the neurodegenerative disease amyotrophic lateral sclerosis.
Pain Assessment and Management Initiative Recognized With 2021 Robert L. Wears Patient Safety Leadership Award
The Pain Assessment and Management Initiative, or PAMI, at the University of Florida College of Medicine – Jacksonville is the 2021 recipient of the Robert L. Wears Patient Safety Leadership Award for the team category.
Economic Impact
Despite the pandemic, University of Florida researchers conducted record amounts of research in 2020 and companies born of UF research continued to bring billions of dollars and thousands of jobs into the state.
ASABE names AGROVIEW winner of a 2021 AE50 award
The American Society of Agricultural and Biological Engineers (ASABE) has named AGROVIEW winner of a 2021 AE50 award.
Purina Announces 2021 Pet Care Innovation Prize Winners
UF startup Structured Monitoring Products' VetGuardian was among the five winners. VetGuardian is a zero-touch remote telemonitor for veterinarians that continuously gathers a patient's vital signs without wires or physical contact.
Skin Cancer Vaccine Developed by Tampa Company Enters Phase 1 of Clinical Trial
UF startup and UF Innovate | Sid Martin Biotech alum Morphogenesis, Inc. completed its first-in-human phase one trial in cutaneous melanoma at Moffitt Cancer Center within the past year and has now moved into studying patients in earlier stages of skin cancers.
Tapeworm, Vertigo and Pancreatitis Drugs Are Being Trialled As COVID-19 Treatments
Included in this news roundup is UF startup Algernon Pharmaceuticals's trials with ifenprodil, a drug used to treat vertigo and bird flu. Algernon is testing the drug's efficacy in preventing lung damage and increasing survivability in patients with COVID-19.
Algernon Pharmaceuticals Receives Green Light from DSMB to Conduct Phase 3 Study of Ifenprodil for COVID-19
UF startup Algernon Pharmaceuticals Inc., formerly known as Breathtec Biomedical, a clinical-stage pharmaceutical development company, announced that the external Data and Safety Monitoring Board (“DSMB”) has completed its latest review of the Phase 2b part of the Company’s Phase 2b/3 human study of NP-120 (Ifenprodil) for the treatment of COVID-19, and has provided approval for the company to continue on with the Phase 3 part of the study.
Abbott Blood Test To Evaluate Mild Concussions Wins FDA Clearance
Doctors soon will have a new way to evaluate patients with concussions: a rapid blood test made by Abbott Laboratories that has been cleared by the U.S. Food and Drug Administration. It’s an advancement that could eliminate the need for some patients to get costly CT scans and the radiation exposure that accompanies them.
Manipulating Milestones in Pandemic Times with AGTC’s Sue Washer
The COVID-19 pandemic continues to disrupt biopharma clinical trials, especially those conducted with at-risk patient populations. From patient recruitment to data collection, clinical trials execution became considerably more challenging in 2020. On this episode of The Business Of Biotech, UF startup and UF Innovate | Sid Martin Biotech graduate AGTC CEO Sue Washer gives us a behind-the-scenes look at the creative measures her company took to serve a geographically dispersed clinical patient population and ensure her company met clinical milestones.
